PHOTO
DUBAI, United Arab Emirates — Zimmer Biomet Holdings, Inc., a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health, has opened a new commercial office in Dubai, United Arab Emirates.
The decision follows years of growing sales of Zimmer Biomet’s advanced technologies, surgical robotics and implants to hospitals and clinics in the Middle East, North Africa and Turkey (MENAT).
Zimmer Biomet’s new office was opened in the same week that the company showcased its industry-leading technologies during the Arab Health 2022 tradeshow at the Dubai World Trade Centre.
“This region has one of the most highly enabled digital populations. We are partnering with hospitals, clinics and health authorities to help them to benefit from Zimmer Biomet’s technology and data to improve efficiency and patient outcomes,” said Erik Antos, Vice President of Emerging Markets, Zimmer Biomet.
The Dubai office will be led by Farah Hamdan, who joined Zimmer Biomet in January 2022 as General Manager for MENAT. Farah brings more than 17 years of experience in healthcare and is responsible for partnering with customers to enhance the quality of care they provide to patients.
“We’re increasing our reach and investment across the region. This means we can partner with even more customers to meet the increasing expectations of patients for personal and connected digital experiences and deliver data-driven insights so they can also improve their efficiency,” Hamdan said.
The opening of Zimmer Biomet’s Dubai office demonstrates the company’s commitment to helping customers maintain momentum during a transformative period in healthcare, and to alleviating pain and improving quality of life for people around the world.
The MENAT region is an important customer base for Zimmer Biomet, with a significant uptick in interest and adoption of its healthcare technologies over the past 10 years.
-Ends-
About the Company
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.
With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation. For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.
Media
Melinda de Boer
Melinda.deBoer@zimmerbiomet.com
© Press Release 2022
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
